Oral and Poster Abstracts
Oral and Poster Abstracts
Oral and Poster Abstracts
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
395 Development of a Program for Disaster Situations <strong>and</strong><br />
Animal Health Emergencies in the X th Region of Chile<br />
G. Monti, G. Ramirez, M. Amtmann<br />
Universidad Austral de Chile, Institute Preventive Veterinary<br />
Medicine, Valdivia, Chile<br />
Objectives of study: It aimed to aware farmers, practitioners <strong>and</strong><br />
authorities on the need <strong>and</strong> strategic importance of develop for animals,<br />
a comprehensive emergency plan or program for disaster situations<br />
(natural or man-made) or animal health emergencies <strong>and</strong> to mitigate<br />
physical <strong>and</strong> economical consequences of calamities though disaster<br />
preparedness.<br />
Materials <strong>and</strong> Methods: The team consists in a Veterinary<br />
Epidemiologist, a Rural development <strong>and</strong> technology transfer specialist<br />
<strong>and</strong> a Public Officer specialized in Public Health. The target audience<br />
was farmers, practitioners, governmental authorities, veterinary<br />
students <strong>and</strong> NGO aid-organizations of the X th region of Chile. The<br />
team tackled the problem by using an approach known as social<br />
marketing (defined asIt consist in participative discussion through<br />
creation of mechanisms that integrate all participants (including social<br />
organizations) for the strategic design of a preparedness plan, with<br />
indicative documents that facilitate the processes that incorporate risk<br />
or uncertainty in the planning of such plan. Expert eliciting techniques<br />
were also used.<br />
Results: Several meetings with different stakeholders (farmers,<br />
practitioners, governmental authorities, military <strong>and</strong> police forces,<br />
veterinary students <strong>and</strong> NGO aid-organizations) took place.<br />
Farmer’s perception of risk was focused on different issues in<br />
comparison with governmental authorities.Chilean society is<br />
undergoing changes in its attitude toward animals. Two of the most<br />
important changes are the urban’s society’s increasing acceptance of<br />
companion animals as family members <strong>and</strong> the increasing<br />
productivity of the animal production units in rural areas. Concurrent<br />
with this change, there is a growing appreciation of the value of the<br />
human-animal bond, improved food safety <strong>and</strong> sustainability aspects<br />
(conservation of the environment, l<strong>and</strong> use <strong>and</strong> quality of life.<br />
Veterinary disaster preparedness interfaces with all of these issues<br />
because they all can become threatened <strong>and</strong> disrupted in disasters.<br />
Conclusions: The project was constructed on the existing knowledge<br />
development of mitigating disaster focused in a cluster of<br />
multidisciplinary team that together contribute towards achieving a<br />
common problem-oriented objective.<br />
Key words: preparedness, disasters, community<br />
396 Flunixin Meglumine (Finadyne ® , Banamine ® ) in Pain<br />
Management of Cattle: Pharmacology <strong>and</strong> Applications<br />
A. Skidmore 1 , J. Roder 1 , J. Van De Ven 2 , P. Cloet 3 , A. Montgomery 4<br />
1<br />
Schering Plough Animal Health, Livestock Technical Services,<br />
Canyon, United States<br />
2<br />
Schering Plough Animal Health, Brussels, Belgium<br />
3<br />
Schering Plough Animal Health, Levallois-Perret Cedex, France<br />
4<br />
Schering Plough Animal Health, Harefield, United Kingdom<br />
Flunixin meglumine (Finadyne ® , Banamine ® ) is a potent, nonsteroidal,<br />
non-narcotic analgesic with anti-inflammatory, antiendotoxic<br />
<strong>and</strong> anti-pyretic properties for use in cattle. Veterinary<br />
products containing flunixin are widely registered for cattle <strong>and</strong><br />
widely used by veterinarians. In cattle, flunixin (Finadyne ®<br />
Solution) is indicated for the control of acute inflammation<br />
associated with respiratory disease. It has also been shown to have<br />
some benefit in the treatment of experimental acute bovine<br />
pulmonary emphysema (Fog Fever). Flunixin also may be used as<br />
adjunctive therapy in the treatment of acute mastitis in dairy<br />
cows. The pharmacology of flunixin is important to underst<strong>and</strong> prior<br />
to therapeutic use in pain management. Flunixin is a weak acid<br />
(pka=5.82) <strong>and</strong> is highly protein bond to plasma proteins in cattle (><br />
99%). After intravenous administration, flunixin (2.2 mg/kg) had a<br />
peak plasma concentration of 16.16 ± 5.28 mcg/ml. The unbound<br />
(free) flunixin is widely distributed throughout the body <strong>and</strong> exhibits<br />
a long elimination half life (6.87 ± 0.49 hours). In horses, flunixin<br />
persists within inflamed tissues <strong>and</strong> is responsible for anti-<br />
Miscellaneous<br />
inflammatory properties well beyond the time of detectable plasma<br />
concentrations. In calves, flunixin administration (2.2 mg/kg i.v.)<br />
resulted in an area under the curve (AUC) of 11.8 µg / h mL -1 <strong>and</strong><br />
27.6 µg / h mL -1 in the plasma <strong>and</strong> acute inflammatory exudate,<br />
respectively. This gives an exudate to plasma ratio of 2.3 for flunixin<br />
indicating greater penetration of the drug in the inflammatory<br />
tissues. Flunixin has shown to significantly improve the pain, edema<br />
<strong>and</strong> temperature (signs of local inflammation) in endotoxin-induced<br />
mastitis of dairy cattle. Flunixin treatment (1 mg/kg) was also<br />
associated with reduction in depression in cows with endotoxininduced<br />
mastitis. In another study, flunixin treatment (2.2 mg/kg)<br />
with an intramammary antibiotic in dairy cows with mastitis reduced<br />
the sensitivity to pain. In registration studies in the USA for a<br />
mastitis claim, flunixin (Banamine ® ) showed a significant reduction<br />
in pain (p=0.0199), swelling (p=0.017) <strong>and</strong> pyrexia (p